Pharmaceutical Executive January 13, 2022
Pharmaceutical Executive Editorial Staff

Nick Cernese is a Health Sciences and Wellness partner at EY. He has spent the last 20 years as a management consultant, leading interdisciplinary teams across the globe and working with large and complex pharmaceutical, medical device, and health technology companies worldwide as they navigate through disruption, innovation and transformation.

He and his team are passionately focused on helping these organizations determine their role in creating platforms that effectively share trusted health-related information. In this way, they are helping individuals make empowered choices about their care.

Pharm Exec: What are the challenges that life sciences companies face today when it comes to putting content out in a timely manner?

Nick Cernese: With the digital technology explosion, there are so many...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Interview / Q&A, Pharma / Biotech, Trends
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article